During the past decade, Rainier Clinical Research Center conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 65 clinical trials were completed, i.e. on average, 64.4% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 31 clinical trials were completed. i.e. 57.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rainier Clinical Research Center" #1 sponsor was "Eli Lilly and Company" with 34 trials, followed by "Medtronic Diabetes" with 20 trials sponsored, "Abbott Diabetes Care" with 9 trials sponsored, "Pfizer" with 9 trials sponsored and "Ascensia Diabetes Care" with 9 trials sponsored. Other sponsors include 62 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rainier Clinical Research Center" #1 collaborator was "Integrium" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Integrated Medical Development" with 3 trials as a collaborator, "Rainier Clinical Research Center" with 2 trials as a collaborator and "AMCR Institute" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "Rainier Clinical Research Center" are "Diabetes Mellitus, Type 2" (14 trials), "Type 1 Diabetes Mellitus" (14 trials), "Type 2 Diabetes" (14 trials), "Type 1 Diabetes" (13 trials) and "Diabetes Mellitus" (12 trials). Many other conditions were trialed in "Rainier Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Rainier Clinical Research Center" are "Drug" (87 trials), "Device" (52 trials), "Biological" (9 trials), "Other" (8 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (39 trials), "Insulin Degludec" (7 trials), "Insulin Lispro" (5 trials), "Tirzepatide" (5 trials) and "Insulin Glargine" (4 trials). Other intervention names were less common.

The vast majority of trials in "Rainier Clinical Research Center" are 140 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Rainier Clinical Research Center". undefined are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Rainier Clinical Research Center, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Rainier Clinical Research Center, 8 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 46 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 41 trials that are defined as “Not Applicable".